We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Landiolol Impurity 9
N-Nitroso Landiolol Impurity 9
CAT No SRC-N0143475
CAS No NA
Mol.F. C13H17N5O7S
Mol.Wt. 387.37g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Landiolol Impurity 10
N-Nitroso Landiolol Impurity 10
CAT No SRC-N0143476
CAS No NA
Mol.F. C25H38N4O9
Mol.Wt. 538.60 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Landiolol Impurity 11
N-Nitroso Landiolol Impurity 11
CAT No SRC-N0143477
CAS No NA
Mol.F. C7H14N4O3
Mol.Wt. 202.21 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Landiolol Impurity 12
N-Nitroso Landiolol Impurity 12
CAT No SRC-N0143478
CAS No NA
Mol.F. C25H36N4O9
Mol.Wt. 536.58 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Landiolol Impurity 13
N-Nitroso Landiolol Impurity 13
CAT No SRC-N0143479
CAS No NA
Mol.F. C20H30N4O7
Mol.Wt. 438.48 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Landiolol Impurity 15
N-Nitroso Landiolol Impurity 15
CAT No SRC-N0143480
CAS No NA
Mol.F. C21H34N4O7S
Mol.Wt. 486.58 g/mole
INV STATUS CUSTOM SYNTHESIS
Moexipril Nitroso Impurity 2
Moexipril Nitroso Impurity 2
CAT No SRC-N0143481
CAS No NA
Mol.F. C10H10N2O6
Mol.Wt. 254.2g/mole
INV STATUS CUSTOM SYNTHESIS
Moexipril Nitroso Impurity 3
Moexipril Nitroso Impurity 3
CAT No SRC-N0143482
CAS No NA
Mol.F. C12H14N2O6
Mol.Wt. 282.3 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Moexipril USP Related Compound A
N-Nitroso Moexipril USP Related Compound A
CAT No SRC-N0143483
CAS No NA
Mol.F. C25H29N3O8
Mol.Wt. 499.52 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Moexipril USP Related Compound D
N-Nitroso Moexipril USP Related Compound D
CAT No SRC-N0143484
CAS No NA
Mol.F. C27H39N3O8
Mol.Wt. 533.62 g/mole
INV STATUS UNDER SYNTHESIS
N-Nitroso Moexipril USP Related Compound F
N-Nitroso Moexipril USP Related Compound F
CAT No SRC-N0143485
CAS No NA
Mol.F. C15H20N2O5
Mol.Wt. 308.33 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Moexipril USP Related Compound G
N-Nitroso Moexipril USP Related Compound G
CAT No SRC-N0143486
CAS No NA
Mol.F. C26H31N3O8
Mol.Wt. 513.55 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Mirogabalin
N-Nitroso Mirogabalin
CAT No SRC-N0143487
CAS No NA
Mol.F. C12H18N2O3
Mol.Wt. 238.29 g/mole
INV STATUS UNDER SYNTHESIS
Mirogabalin Nitroso Impurity 1
Mirogabalin Nitroso Impurity 1
CAT No SRC-N0143488
CAS No NA
Mol.F. C16H26N2O3
Mol.Wt. 294.40 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Xanomeline Ethoxy impurity
N-Nitroso Xanomeline Ethoxy impurity
CAT No SRC-N0143489
CAS No NA
Mol.F. C9H12N4O2S
Mol.Wt. 240.28 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Xanomeline Impurity 7
N-Nitroso Xanomeline Impurity 7
CAT No SRC-N0143490
CAS No NA
Mol.F. C13H20N4O2S
Mol.Wt. 296.39 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.